全文获取类型
收费全文 | 2005篇 |
免费 | 113篇 |
国内免费 | 24篇 |
专业分类
耳鼻咽喉 | 16篇 |
儿科学 | 84篇 |
妇产科学 | 33篇 |
基础医学 | 226篇 |
口腔科学 | 20篇 |
临床医学 | 184篇 |
内科学 | 390篇 |
皮肤病学 | 75篇 |
神经病学 | 186篇 |
特种医学 | 133篇 |
外科学 | 350篇 |
综合类 | 11篇 |
预防医学 | 129篇 |
眼科学 | 98篇 |
药学 | 116篇 |
中国医学 | 2篇 |
肿瘤学 | 89篇 |
出版年
2023年 | 6篇 |
2022年 | 15篇 |
2021年 | 33篇 |
2020年 | 14篇 |
2019年 | 42篇 |
2018年 | 49篇 |
2017年 | 34篇 |
2016年 | 37篇 |
2015年 | 52篇 |
2014年 | 34篇 |
2013年 | 82篇 |
2012年 | 86篇 |
2011年 | 109篇 |
2010年 | 85篇 |
2009年 | 70篇 |
2008年 | 102篇 |
2007年 | 99篇 |
2006年 | 84篇 |
2005年 | 113篇 |
2004年 | 78篇 |
2003年 | 96篇 |
2002年 | 85篇 |
2001年 | 64篇 |
2000年 | 102篇 |
1999年 | 68篇 |
1998年 | 41篇 |
1997年 | 52篇 |
1996年 | 50篇 |
1995年 | 34篇 |
1994年 | 21篇 |
1993年 | 10篇 |
1992年 | 34篇 |
1991年 | 21篇 |
1990年 | 33篇 |
1989年 | 30篇 |
1988年 | 30篇 |
1987年 | 13篇 |
1986年 | 23篇 |
1985年 | 19篇 |
1984年 | 6篇 |
1983年 | 20篇 |
1982年 | 7篇 |
1981年 | 5篇 |
1980年 | 6篇 |
1978年 | 5篇 |
1977年 | 9篇 |
1976年 | 8篇 |
1975年 | 5篇 |
1966年 | 4篇 |
1965年 | 4篇 |
排序方式: 共有2142条查询结果,搜索用时 15 毫秒
101.
102.
103.
Lleó Pérez A Hernández Pérez D Hernández Martínez FJ Navarro Palop C Marcos Jorge A Pallas Ventayol C 《Archivos de la Sociedad Espa?ola de Oftalmología》2000,75(8):555-558
PURPOSE/METHODS: Serpiginous choroiditis is a rare, chronic, progressive, and recurrent bilateral disorder primarily involving the choriocapillaris and the retinal pigment epithelium. Progression typically occurs as pseudopodia extensions away from the optic discs and usually infringes upon the macula and foveal region. RESULTS/CONCLUSIONS: We studied three cases of geographic choroidopathy, showing the ophthalmoscopic picture and the fluorescein angiographic of the fundus oculi, characterised by typical disease lesions. Finally, some considerations in differential diagnosis between pigment epithelium inflammatory diseases will be reported. 相似文献
104.
105.
106.
Combined pharmacologic therapy in a rabbit model of proliferative vitreoretinopathy (PVR) 总被引:4,自引:0,他引:4
PURPOSE: This study was designed to evaluate the efficacy of a combined treatment, previously used to prevent fibrosis after glaucoma surgery, to inhibit an experimental model of proliferative vitreoretinopathy (PVR). METHODS: Two groups of albino rabbits were used. In the control group (group 1, n = 14), experimental PVR was induced using vitrectomy, retinotomies, cryotherapy and intraocular injection of platelet-rich plasma. In the experimental group (group 2, n = 15), after PVR was induced, the following treatment was administered for 4 weeks: systemic methylprednisolone, sodium diclofenac and colchicine combined with topical atropine 1%, adrenaline 10% and dexamethasone phosphate 0.1%. Follow- up consisted of fundus examination for 4 weeks. Results were classified according to Fastenberg's classification. Only retinal detachments were considered to compare the two groups. Nonparametric test was used. RESULTS: Retinal detachments were observed in 85.7% of group 1 and 33.3% of group 2 at the end of the follow-up (p<0.01). No major systemic complications were observed. CONCLUSIONS: Combined therapy seems to be useful for treating experimental PVR. 相似文献
107.
Stewart WC Sharpe ED Harbin TS Pastor SA Day DG Holmes KT Stewart JA 《American journal of ophthalmology》2000,129(6):165-727
PURPOSE: To evaluate the efficacy and safety of brimonidine compared with dorzolamide given three times daily as monotherapy in patients with primary open-angle glaucoma or ocular hypertension. METHODS: In a double-masked, multicenter, crossover comparison in 40 patients, qualified patients were washed out from their previous medication and randomized to dorzolamide 2% or brimonidine 0.2% for the first 6-week treatment period. Patients then were washed out for 2 weeks and started on the opposite medication for the second 6-week period. RESULTS: Baseline intraocular pressure for all 40 subjects (76 eyes) was 24.1 +/- 2.0 mm Hg. This study found that the 8:00 AM trough intraocular pressure after 6 weeks of therapy for dorzolamide was 20. 7 +/- 3.1 mm Hg and for brimonidine 20.8 +/- 3.2 mm Hg (P =.99). The peak intraocular pressure (2 hours after dosing) for dorzolamide was 18.6 +/- 3.4 mm Hg and for brimonidine 17.8 +/- 2.7 mm Hg (P =.10 ). Dorzolamide caused more stinging upon instillation (P <.01) and brimonidine more itching (P =.01). No statistical differences existed between groups for systemic adverse events. Six patients, all on brimonidine, were discontinued from a treatment period early. Of these, two were discontinued for inadequate pressure control, two with dizziness and fatigue, one with ocular pain, and one for lifestyle reasons (P =.07). CONCLUSIONS: This study found similar efficacy and safety between monotherapy treatment with dorzolamide or brimonidine when each was given three times daily to patients with ocular hypertension or primary open-angle glaucoma. 相似文献
108.
Automated perimetry: a report by the American Academy of Ophthalmology 总被引:10,自引:0,他引:10
Delgado MF Nguyen NT Cox TA Singh K Lee DA Dueker DK Fechtner RD Juzych MS Lin SC Netland PA Pastor SA Schuman JS Samples JR;American Academy of Ophthalmology. Ophthalmic Technology Assessment Committee - Glaucoma Panel 《Ophthalmology》2002,109(12):247-2374
OBJECTIVE: The purpose of this document is to summarize and evaluate the effectiveness of new automated perimetry tests and algorithms in diagnosing glaucoma and detecting disease progression. METHODS: A literature search on automated perimetry retrieved over 300 citations from 1994 to 2001, of which 71 were selected as relevant to this assessment. The quality of the evidence obtained from these studies was assessed by the methodologist. RESULTS: The four automated perimetry techniques described in this assessment are short wavelength automated perimetry (SWAP), frequency doubling technology perimetry (FDT), high-pass resolution perimetry (HPRP), and motion automated perimetry (MAP). The algorithms described are Swedish interactive threshold algorithm (SITA) and SITA fast. With the exception of SWAP, these techniques and algorithms reduce testing time and inconsistent patient performance when compared with conventional full threshold testing. CONCLUSIONS: Short wavelength automated perimetry detected visual field loss earlier than standard threshold automated perimetry, with a sensitivity and specificity of about 88% and 92% respectively. However, it is a lengthy, demanding test, is sensitive to media opacities, and has a greater magnitude of long-term fluctuation compared with standard threshold automated perimetry, which make it difficult to assess disease progression accurately. When compared to standard threshold automated perimetry, FDT perimetry showed sensitivity and specificity greater than 97% for detecting moderate and advanced glaucoma, and sensitivity of 85% and specificity of 90% for early glaucoma. As FDT perimetry has a short testing time and is resistant to blur and pupil size, it may be a useful screening tool. In a longitudinal study, high-pass resolution perimetry was more effective than standard threshold automated perimetry in monitoring progressive glaucomatous loss, detecting progression at a median of 12 months earlier in 54% of patients studied. Motion automated perimetry demonstrated usefulness in detecting early glaucomatous visual loss in a longitudinal study. Studies on SITA demonstrated greater sensitivity and reproducibility and less intertest variability when compared to standard full threshold testing and a 50% reduction in testing times. A study comparing standard full threshold, SITA, and SITA fast found a sensitivity of 95% for the first two techniques and 93% for SITA fast. Long-term follow-up studies are needed to assess the ability of these techniques to detect progression of glaucoma over time. 相似文献
109.
Proliferative vitreoretinopathy: risk factors and pathobiology 总被引:14,自引:0,他引:14
Proliferative vitreoretinopathy (PVR) is still a major cause of failure of retinal detachment surgery. Despite a dramatic increase in our pathobiologic knowledge of PVR during the last 10 years, little of this information has been used to modify the surgical management of the disease, and, thus, the anatomic and functional results are still unsatisfactory. Collaborative research involving clinicians and basic researchers must be encouraged. PVR must be considered a multifactorial disease caused by interaction of several cells and intra- and extraocular factors. Therefore, therapeutic options based on the inhibition of one factor or phenomenon may be regarded with scepticism. To prevent PVR, it is necessary to determine the factors involved in its development, and because of its relatively small prevalence, large, prospective, multicenter studies seem necessary. In addition, clinical research must not be underestimated. PVR affects both sides of the retina and the retina itself, a point to which little attention has been paid and that is critical for surgical results. Therefore, a new classification that provides information about clinical relevance, such as the evolutionary stages of the disease (biologic activity) and the degree of surgical difficulty (location of the fibrotic process), seems necessary. 相似文献
110.